KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Moderna (MRNA) Other Gross PP&E Adjustments (2017 - 2025)

Moderna (MRNA) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 10.37% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 10.37% increase, with the full-year FY2025 number at $2.0 billion, up 10.37% from a year prior.
  • Other Gross PP&E Adjustments was $2.0 billion for Q4 2025 at Moderna, down from $2.8 billion in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.0 billion in Q2 2023 to a low of $408.0 million in Q1 2021.
  • A 5-year average of $1.9 billion and a median of $2.0 billion in 2025 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 378.57% in 2021, then plummeted 37.52% in 2023.
  • Moderna's Other Gross PP&E Adjustments stood at $1.4 billion in 2021, then surged by 76.76% to $2.5 billion in 2022, then plummeted by 37.52% to $1.6 billion in 2023, then increased by 17.95% to $1.8 billion in 2024, then increased by 10.37% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Other Gross PP&E Adjustments are $2.0 billion (Q4 2025), $2.8 billion (Q3 2025), and $2.0 billion (Q2 2025).